Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stas

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Acta Chirurgica Belgica|December 5, 2008
Radiation-induced sarcoma: analysis of 46 casesS De Smet, L Vandermeeren, M-R Christiaens, et al.
Histopathology|November 14, 1997
Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomasP Dal Cin, R Sciot, P Polito, et al.
Melanoma Research|October 24, 2002
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impactM Stas, S Stroobants, P Dupont, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2005
Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examinationT Nijsten, C Leys, K Verbruggen, et al.
Skeletal Radiology|February 1, 2000
Proliferative myositis in a childS Mulier, M Stas, J Delabie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Recommendations for skin cancer consultation and surgery during COVID-19 pandemicL Brochez, J F Baurain, V Del Marmol, et al.
Genes, Chromosomes & Cancer|June 1, 1994
Some desmoid tumors are characterized by trisomy 8P Dal Cin, R Sciot, M S Aly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2013
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trialG A Goossens, M Jérôme, C Janssens, et al.
Cancer Research|June 19, 2001
A novel N-ras mutation in malignant melanoma is associated with excellent prognosisA Demunter, M R Ahmadian, L Libbrecht, et al.
The American Journal of Pathology|December 1, 1996
CD40 is a prognostic marker in primary cutaneous malignant melanomaJ J van den Oord, A Maes, M Stas, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Acta Chirurgica Belgica|December 5, 2008
Radiation-induced sarcoma: analysis of 46 casesS De Smet, L Vandermeeren, M-R Christiaens, et al.
Histopathology|November 14, 1997
Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomasP Dal Cin, R Sciot, P Polito, et al.
Melanoma Research|October 24, 2002
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impactM Stas, S Stroobants, P Dupont, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2005
Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examinationT Nijsten, C Leys, K Verbruggen, et al.
Skeletal Radiology|February 1, 2000
Proliferative myositis in a childS Mulier, M Stas, J Delabie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Recommendations for skin cancer consultation and surgery during COVID-19 pandemicL Brochez, J F Baurain, V Del Marmol, et al.
Genes, Chromosomes & Cancer|June 1, 1994
Some desmoid tumors are characterized by trisomy 8P Dal Cin, R Sciot, M S Aly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2013
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trialG A Goossens, M Jérôme, C Janssens, et al.
Cancer Research|June 19, 2001
A novel N-ras mutation in malignant melanoma is associated with excellent prognosisA Demunter, M R Ahmadian, L Libbrecht, et al.
The American Journal of Pathology|December 1, 1996
CD40 is a prognostic marker in primary cutaneous malignant melanomaJ J van den Oord, A Maes, M Stas, et al.
Pageof 5